Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | DHFR | P00374 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TYMP | P19971 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12539378 | 0.83 | KMT2A (0.43) | KMT2AKCNH2MEN1ALDH1A1PKM | |
| SCHEMBL12539352 | 0.82 | KMT2A (0.42) | KMT2AKCNH2MEN1ALDH1A1PKM | |
| SCHEMBL8040945 | 0.82 | KMT2A (0.42) | KMT2AKCNH2MEN1ALDH1A1PKM | |
| SCHEMBL1685610 | 0.80 | PTGS2 (0.38) | KMT2AKCNH2MEN1ALDH1A1PKM | |
| SCHEMBL12539248 | 0.73 | KCNH2 (0.39) | KCNH2ALDH1A1DHFRLMNATDP1 | |
| SCHEMBL10818337 | 0.73 | KMT2A (0.37) | KMT2AKCNH2MEN1ALDH1A1PKM | |
| SCHEMBL11413687 | 0.72 | KMT2A (0.44) | KMT2AKCNH2ALDH1A1PKMHPGD | |
| SCHEMBL4405124 | 0.72 | KMT2A (0.44) | KMT2AKCNH2ALDH1A1PKMHPGD | |
| SCHEMBL10992770 | 0.72 | KMT2A (0.44) | KMT2AKCNH2ALDH1A1PKMHPGD | |
| SCHEMBL11417577 | 0.72 | KMT2A (0.44) | KMT2AKCNH2ALDH1A1PKMHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8697256-B2 | Composition comprising phosphorescent compound and light emitting device using the composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-04-15 | — | — | US | disclosed |
| EP-2116574-B1 | COMPOSITION CONTAINING PYRIMIDINE COMPOUND AND LUMINESCENT ELEMENT EMPLOYING THE COMPOSITION | SUMITOMO CHEMICAL CO (JP) | 2013-07-10 | — | — | EP | disclosed |
| CN-101616986-B | Composition containing pyrimidine compound and luminescent element employing the composition | SUMITOMO CO LTD | 2012-11-28 | — | — | CN | disclosed |
| CN-102105530-A | Composition comprising phosphorescence emitting compound, and light emitting element using the composition | SUMITOMO CHEMICAL CO | 2011-06-22 | — | — | CN | disclosed |
| US-20110127467-A1 | COMPOSITION COMPRISING PHOSPHORESCENT COMPOUND AND LIGHT EMITTING DEVICE USING THE COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-06-02 | — | — | US | disclosed |
| EP-2308926-A1 | COMPOSITION COMPRISING PHOSPHORESCENCE EMITTING COMPOUND, AND LIGHT EMITTING ELEMENT USING THE COMPOSITION | Sumitomo Chemical Company, Limited (JP) | 2011-04-13 | — | — | EP | disclosed |
| US-20100019203-A1 | COMPOSITION CONTAINING PYRIMIDINE COMPOUND AND LUMINESCENT ELEMENT EMPLOYING THE COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-01-28 | — | — | US | disclosed |
| CN-101616986-A | Contain the composition of pyrimidine compound and the luminous element that uses said composition to obtain | SUMITOMO CHEMICAL CO | 2009-12-30 | — | — | CN | disclosed |
| EP-2116574-A1 | COMPOSITION CONTAINING PYRIMIDINE COMPOUND AND LUMINESCENT ELEMENT EMPLOYING THE COMPOSITION | Sumitomo Chemical Company, Limited (JP) | 2009-11-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110127467-A1 | COMPOSITION COMPRISING PHOSPHORESCENT COMPOUND AND LIGHT EMITTING DEVICE USING THE COMPOSITION | CCNE2, CDCA2, CCNA2 | KMT2A 2232/4885KCNH2 2502/4885MEN1 267/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.